Items where Funder is Nuvasive INC.
Up a levelJump to: NO EXT REF GIVEN | S-16-132E
Number of items: 2.
NO EXT REF GIVEN
El-Sherbiny, YM orcid.org/0000-0003-4791-3475, El-Jawhari, JJ orcid.org/0000-0002-0580-4492, Moseley, TA et al. (2 more authors) (2018) T cell immunomodulation by clinically used allogeneic human cancellous bone fragments: a potential novel immunotherapy tool. Scientific Reports, 8 (1). ARTN13535. ISSN 2045-2322
S-16-132E
El-Sherbiny, YM orcid.org/0000-0003-4791-3475, El-Jawhari, JJ orcid.org/0000-0002-0580-4492, Moseley, TA et al. (2 more authors) (2018) T cell immunomodulation by clinically used allogeneic human cancellous bone fragments: a potential novel immunotherapy tool. Scientific Reports, 8 (1). ARTN13535. ISSN 2045-2322